{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:41:01Z","timestamp":1792788061833,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research Project of Jinan Microecological Biomedicine Shandong Laboratory","award":["JNL-2023017D"],"award-info":[{"award-number":["JNL-2023017D"]}]},{"name":"Research Project of Jinan Microecological Biomedicine Shandong Laboratory","award":["JNL-2025008B"],"award-info":[{"award-number":["JNL-2025008B"]}]},{"name":"Research Project of Jinan Microecological Biomedicine Shandong Laboratory","award":["JNL-2025011B"],"award-info":[{"award-number":["JNL-2025011B"]}]},{"name":"Research Project of Jinan Microecological Biomedicine Shandong Laboratory","award":["JNL-2025009B"],"award-info":[{"award-number":["JNL-2025009B"]}]},{"name":"Shandong Provincial Laboratory Project","award":["SYS202202"],"award-info":[{"award-number":["SYS202202"]}]},{"name":"Primary Research and Development Plan of Jiangsu Province","award":["BE2022840"],"award-info":[{"award-number":["BE2022840"]}]},{"name":"Shandong Provincial Natural Science Foundation","award":["ZR2025MS1306"],"award-info":[{"award-number":["ZR2025MS1306"]}]},{"name":"National Natural Science Foundation of China","award":["82272819 and 81972888"],"award-info":[{"award-number":["82272819 and 81972888"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Key R&D Program of Shandong Province","award":["2025CXPT176"],"award-info":[{"award-number":["2025CXPT176"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-026-04994-7","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:57:08Z","timestamp":1782741428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An ICOSL-armed oncolytic adenovirus activates CD4+ T cell to potentiate antitumor immunity and synergizes with anti-PD-1 or CAR-T cell therapy in colorectal cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Wencui","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanqi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilei","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingkai","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciliang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"issue":"10512","key":"4994_CR1","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0140-6736(25)01635-6","volume":"406","author":"The global","year":"2025","unstructured":"The global. regional, and national burden of cancer, 1990\u20132023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. 2025;406(10512):1565\u201386.","journal-title":"Lancet"},{"issue":"1","key":"4994_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1200\/JCO.18.00032","volume":"37","author":"A Ogura","year":"2019","unstructured":"Ogura A, Konishi T, Cunningham C, Garcia-Aguilar J, Iversen H, Toda S, Lee IK, Lee HX, Uehara K, Lee P, et al. Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3\/4 Rectal Cancer. J Clin Oncol. 2019;37(1):33\u201343.","journal-title":"J Clin Oncol"},{"key":"4994_CR3","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.3389\/fimmu.2020.01624","volume":"11","author":"NA Johdi","year":"2020","unstructured":"Johdi NA, Sukor NF. Colorectal Cancer Immunotherapy: Options and Strategies. Front Immunol. 2020;11:1624.","journal-title":"Front Immunol"},{"issue":"11","key":"4994_CR4","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","volume":"20","author":"AD Waldman","year":"2020","unstructured":"Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol. 2020;20(11):651\u201368.","journal-title":"Nat Rev Immunol"},{"issue":"626","key":"4994_CR5","doi-asserted-by":"publisher","first-page":"eabf0992","DOI":"10.1126\/scitranslmed.abf0992","volume":"14","author":"S Shang","year":"2022","unstructured":"Shang S, Yang YW, Chen F, Yu L, Shen SH, Li K, Cui B, Lv XX, Zhang C, Yang C, et al. TRIB3 reduces CD8(+) T cell infiltration and induces immune evasion by repressing the STAT1-CXCL10 axis in colorectal cancer. Sci Transl Med. 2022;14(626):eabf0992.","journal-title":"Sci Transl Med"},{"issue":"11","key":"4994_CR6","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1158\/2767-9764.CRC-25-0332","volume":"5","author":"RW Lentz","year":"2025","unstructured":"Lentz RW, Lang J, Pitts TM, Blatchford P, Hu J, Jordan KR, Van Bokhoven A, Bagby SM, Dominguez ATA, Binns CA, et al. Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer. Cancer Res Commun. 2025;5(11):2039\u201352.","journal-title":"Cancer Res Commun"},{"issue":"4","key":"4994_CR7","doi-asserted-by":"publisher","first-page":"e006561","DOI":"10.1136\/jitc-2022-006561","volume":"11","author":"M Fakih","year":"2023","unstructured":"Fakih M, Harb W, Mahadevan D, Babiker H, Berlin J, Lillie T, Krige D, Carter J, Cox C, Patel M, et al. Safety and efficacy of the tumor-selective adenovirus enadenotucirev, in combination with nivolumab, in patients with advanced\/metastatic epithelial cancer: a phase I clinical trial (SPICE). J Immunother Cancer. 2023;11(4):e006561.","journal-title":"J Immunother Cancer"},{"issue":"9","key":"4994_CR8","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nrd4663","volume":"14","author":"HL Kaufman","year":"2015","unstructured":"Kaufman HL, Kohlhapp FJ, Zloza A. Oncolytic viruses: a new class of immunotherapy drugs. Nat Rev Drug Discov. 2015;14(9):642\u201362.","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"4994_CR9","first-page":"7277","volume":"9","author":"P Mohite","year":"2024","unstructured":"Mohite P, Yadav V, Pandhare R, Maitra S, Saleh FM, Saleem RM, Al-Malky HS, Kumarasamy V, Subramaniyan V, Abdel-Daim MM, et al. Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of Immunotherapy. ACS Omega. 2024;9(7):7277\u201395.","journal-title":"ACS Omega"},{"key":"4994_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/978-3-319-67577-0_11","volume":"1036","author":"SE Berkey","year":"2017","unstructured":"Berkey SE, Thorne SH, Bartlett DL. Oncolytic Virotherapy and the Tumor Microenvironment. Adv Exp Med Biol. 2017;1036:157\u201372.","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"4994_CR11","doi-asserted-by":"publisher","first-page":"102399","DOI":"10.1016\/j.xcrm.2025.102399","volume":"6","author":"C Guo","year":"2025","unstructured":"Guo C, Gao T, Xue B, Zhang L, Wang S, Xiao R, Kong L, Zhang Y, Xin Q, Cao Y, et al. In situ extended immune activation instantly after tumor resection by oncolytic virus controls postoperative tumor recurrence. Cell Rep Med. 2025;6(10):102399.","journal-title":"Cell Rep Med"},{"key":"4994_CR12","doi-asserted-by":"publisher","first-page":"574007","DOI":"10.3389\/fbioe.2020.574007","volume":"8","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wu J, Zhang H, Wei J, Wu J. Extracellular Vesicles-Mimetic Encapsulation Improves Oncolytic Viro-Immunotherapy in Tumors With Low Coxsackie and Adenovirus Receptor. Front Bioeng Biotechnol. 2020;8:574007.","journal-title":"Front Bioeng Biotechnol"},{"issue":"10","key":"4994_CR13","doi-asserted-by":"publisher","first-page":"101751","DOI":"10.1016\/j.xcrm.2024.101751","volume":"5","author":"K Liu","year":"2024","unstructured":"Liu K, Kong L, Cui H, Zhang L, Xin Q, Zhuang Y, Guo C, Yao Y, Tao J, Gu X, et al. Thymosin \u03b11 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy. Cell Rep Med. 2024;5(10):101751.","journal-title":"Cell Rep Med"},{"key":"4994_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.omto.2020.11.001","volume":"20","author":"H Zhang","year":"2021","unstructured":"Zhang H, Zhang Y, Dong J, Li B, Xu C, Wei M, Wu J, Wei J. Recombinant oncolytic adenovirus expressing a soluble PVR elicits long-term antitumor immune surveillance. Mol Ther Oncolytics. 2021;20:12\u201322.","journal-title":"Mol Ther Oncolytics"},{"issue":"6","key":"4994_CR15","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s13402-021-00633-w","volume":"44","author":"H Zhang","year":"2021","unstructured":"Zhang H, Zhang Y, Dong J, Zuo S, Meng G, Wu J, Wei J. Recombinant adenovirus expressing the fusion protein PD1PVR improves CD8(+) T cell-mediated antitumor efficacy with long-term tumor-specific immune surveillance in hepatocellular carcinoma. Cell Oncol (Dordr). 2021;44(6):1243\u201355.","journal-title":"Cell Oncol (Dordr)"},{"key":"4994_CR16","doi-asserted-by":"publisher","first-page":"103240","DOI":"10.1016\/j.ebiom.2021.103240","volume":"64","author":"S Zuo","year":"2021","unstructured":"Zuo S, Wei M, He B, Chen A, Wang S, Kong L, Zhang Y, Meng G, Xu T, Wu J, et al. Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against T-cell immunoglobulin and ITIM domain (TIGIT). EBioMedicine. 2021;64:103240.","journal-title":"EBioMedicine"},{"issue":"2","key":"4994_CR17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0092-8674(93)80063-K","volume":"75","author":"J Zabner","year":"1993","unstructured":"Zabner J, Couture LA, Gregory RJ, Graham SM, Smith AE, Welsh MJ. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell. 1993;75(2):207\u201316.","journal-title":"Cell"},{"issue":"8","key":"4994_CR18","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1158\/1078-0432.CCR-21-3324","volume":"28","author":"EHP van Putten","year":"2022","unstructured":"van Putten EHP, Kleijn A, van Beusechem VW, Noske D, Lamers CHJ, de Goede AL, Idema S, Hoefnagel D, Kloezeman JJ, Fueyo J, et al. Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM: A Phase I Clinical Trial Including Correlative Studies. Clin Cancer Res. 2022;28(8):1572\u201385.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"4994_CR19","doi-asserted-by":"publisher","first-page":"e003645","DOI":"10.1136\/jitc-2021-003645","volume":"9","author":"V Moreno","year":"2021","unstructured":"Moreno V, Barretina-Ginesta MP, Garc\u00eda-Donas J, Jayson GC, Roxburgh P, V\u00e1zquez RM, Ant\u00f3n-Torres MA, Brown A, Krige R. D: Safety and efficacy of the tumor-selective adenovirus enadenotucirev with or without paclitaxel in platinum-resistant ovarian cancer: a phase 1 clinical trial. J Immunother Cancer. 2021;9(12):e003645.","journal-title":"J Immunother Cancer"},{"key":"4994_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/B978-0-12-398342-8.00004-5","volume":"115","author":"R Alemany","year":"2012","unstructured":"Alemany R. Chapter four\u2013Design of improved oncolytic adenoviruses. Adv Cancer Res. 2012;115:93\u2013114.","journal-title":"Adv Cancer Res"},{"issue":"1","key":"4994_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13046-025-03358-y","volume":"44","author":"S Wang","year":"2025","unstructured":"Wang S, Kong L, Wang L, Zhuang Y, Guo C, Zhang Y, Cui H, Gu X, Wu J, Jiang C. Viral expression of NE\/PPE enhances anti-colorectal cancer efficacy of oncolytic adenovirus by promoting TAM M1 polarization to reverse insufficient effector memory\/effector CD8(+) T cell infiltration. J Exp Clin Cancer Res. 2025;44(1):97.","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"4994_CR22","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41577-018-0044-0","volume":"18","author":"J Borst","year":"2018","unstructured":"Borst J, Ahrends T, B\u0105ba\u0142a N, Melief CJM, Kastenm\u00fcller W. CD4(+) T cell help in cancer immunology and immunotherapy. Nat Rev Immunol. 2018;18(10):635\u201347.","journal-title":"Nat Rev Immunol"},{"issue":"6716","key":"4994_CR23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/16717","volume":"397","author":"A Hutloff","year":"1999","unstructured":"Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, Anagnostopoulos I, Kroczek RA. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature. 1999;397(6716):263\u20136.","journal-title":"Nature"},{"issue":"3","key":"4994_CR24","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.coi.2010.01.001","volume":"22","author":"TR Simpson","year":"2010","unstructured":"Simpson TR, Quezada SA, Allison JP. Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS). Curr Opin Immunol. 2010;22(3):326\u201332.","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"4994_CR25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3390\/pharmaceutics13040547","volume":"13","author":"M Garofalo","year":"2021","unstructured":"Garofalo M, Bertinato L, Staniszewska M, Wieczorek M, Salmaso S, Schrom S, Rinner B, Pancer KW, Kuryk L. Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model. Pharmaceutics. 2021;13(4):547.","journal-title":"Pharmaceutics"},{"issue":"1","key":"4994_CR26","doi-asserted-by":"publisher","first-page":"5066","DOI":"10.1038\/s41467-020-18828-4","volume":"11","author":"E Rujas","year":"2020","unstructured":"Rujas E, Cui H, Sicard T, Semesi A, Julien JP. Structural characterization of the ICOS\/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies. Nat Commun. 2020;11(1):5066.","journal-title":"Nat Commun"},{"issue":"8","key":"4994_CR27","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1182\/blood.V96.8.2808","volume":"96","author":"S Wang","year":"2000","unstructured":"Wang S, Zhu G, Chapoval AI, Dong H, Tamada K, Ni J, Chen L. Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood. 2000;96(8):2808\u201313.","journal-title":"Blood"},{"issue":"9","key":"4994_CR28","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.1073\/pnas.93.9.4165","volume":"93","author":"GO Gaufo","year":"1996","unstructured":"Gaufo GO, Diamond MC. Prolactin increases CD4\/CD8 cell ratio in thymus-grafted congenitally athymic nude mice. Proc Natl Acad Sci U S A. 1996;93(9):4165\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"4994_CR29","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1182\/blood-2006-04-017061","volume":"108","author":"J Vera","year":"2006","unstructured":"Vera J, Savoldo B, Vigouroux S, Biagi E, Pule M, Rossig C, Wu J, Heslop HE, Rooney CM, Brenner MK, et al. T lymphocytes redirected against the kappa light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells. Blood. 2006;108(12):3890\u20137.","journal-title":"Blood"},{"issue":"5","key":"4994_CR30","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.ymthe.2005.04.016","volume":"12","author":"MA Pul\u00e8","year":"2005","unstructured":"Pul\u00e8 MA, Straathof KC, Dotti G, Heslop HE, Rooney CM, Brenner MK. A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells. Mol Ther. 2005;12(5):933\u201341.","journal-title":"Mol Ther"},{"issue":"5","key":"4994_CR31","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1172\/JCI46110","volume":"121","author":"B Savoldo","year":"2011","unstructured":"Savoldo B, Ramos CA, Liu E, Mims MP, Keating MJ, Carrum G, Kamble RT, Bollard CM, Gee AP, Mei Z, et al. CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients. J Clin Invest. 2011;121(5):1822\u20136.","journal-title":"J Clin Invest"},{"issue":"1","key":"4994_CR32","doi-asserted-by":"publisher","first-page":"e86348","DOI":"10.1371\/journal.pone.0086348","volume":"9","author":"T Trautmann","year":"2014","unstructured":"Trautmann T, Kozik JH, Carambia A, Richter K, Lischke T, Schwinge D, Mittr\u00fccker HW, Lohse AW, Oxenius A, Wiegard C, et al. CD4\u2009+\u2009T-cell help is required for effective CD8\u2009+\u2009T cell-mediated resolution of acute viral hepatitis in mice. PLoS ONE. 2014;9(1):e86348.","journal-title":"PLoS ONE"},{"issue":"5","key":"4994_CR33","doi-asserted-by":"publisher","first-page":"e0182524","DOI":"10.1128\/jvi.01825-24","volume":"99","author":"DP Sequeira","year":"2025","unstructured":"Sequeira DP, Suomalainen M, Freitag PC, Pl\u00fcckthun A, Klingenbrunner M, Fischer L, Hemmi S, M\u00fcnz C, Volle R, Greber UF. Activated blood-derived human primary T cells support replication of HAdV C5 and virus transmission to polarized human primary epithelial cells. J Virol. 2025;99(5):e0182524.","journal-title":"J Virol"},{"issue":"5286","key":"4994_CR34","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.274.5286.373","volume":"274","author":"JR Bischoff","year":"1996","unstructured":"Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M, Ng L, Nye JA, Sampson-Johannes A, Fattaey A, et al. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science. 1996;274(5286):373\u20136.","journal-title":"Science"},{"issue":"22","key":"4994_CR35","doi-asserted-by":"publisher","first-page":"18934","DOI":"10.1074\/jbc.M101103200","volume":"276","author":"LV Madrid","year":"2001","unstructured":"Madrid LV, Mayo MW, Reuther JY, Baldwin AS Jr. Akt stimulates the transactivation potential of the RelA\/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem. 2001;276(22):18934\u201340.","journal-title":"J Biol Chem"},{"issue":"4903","key":"4994_CR36","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1126\/science.2497518","volume":"244","author":"B Hoyos","year":"1989","unstructured":"Hoyos B, Ballard DW, B\u00f6hnlein E, Siekevitz M, Greene WC. Kappa B-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression. Science. 1989;244(4903):457\u201360.","journal-title":"Science"},{"issue":"16","key":"4994_CR37","doi-asserted-by":"publisher","first-page":"5445","DOI":"10.1158\/0008-5472.CAN-11-1138","volume":"71","author":"T Fu","year":"2011","unstructured":"Fu T, He Q, Sharma P. The ICOS\/ICOSL pathway is required for optimal antitumor responses mediated by anti-CTLA-4 therapy. Cancer Res. 2011;71(16):5445\u201354.","journal-title":"Cancer Res"},{"issue":"10","key":"4994_CR38","doi-asserted-by":"publisher","first-page":"e99048","DOI":"10.1172\/jci.insight.99048","volume":"3","author":"D Wang","year":"2018","unstructured":"Wang D, Aguilar B, Starr R, Alizadeh D, Brito A, Sarkissian A, Ostberg JR, Forman SJ, Brown CE. Glioblastoma-targeted CD4\u2009+\u2009CAR T cells mediate superior antitumor activity. JCI Insight. 2018;3(10):e99048.","journal-title":"JCI Insight"},{"issue":"7","key":"4994_CR39","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s43018-023-00567-2","volume":"4","author":"ME Kohler","year":"2023","unstructured":"Kohler ME, Fry TJ. CD4(+) CAR T cells - more than helpers. Nat Cancer. 2023;4(7):928\u20139.","journal-title":"Nat Cancer"},{"issue":"6","key":"4994_CR40","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41417-025-00901-z","volume":"32","author":"TV Kudling","year":"2025","unstructured":"Kudling TV, Bychkov D, Clubb JHA, Pakola SA, Arias V, Jirovec E, van der Heijden M, Ojala N, Quixabeira DCA, Haybout L, et al. Single-cell profiling of peripheral blood mononuclear cells from patients treated with oncolytic adenovirus TILT-123 reveals baseline immune status as a predictor of therapy outcomes. Cancer Gene Ther. 2025;32(6):649\u201361.","journal-title":"Cancer Gene Ther"},{"issue":"29","key":"4994_CR41","doi-asserted-by":"publisher","first-page":"e2408649121","DOI":"10.1073\/pnas.2408649121","volume":"121","author":"E Tili","year":"2024","unstructured":"Tili E, Otsu H, Commisso TL, Palamarchuk A, Balatti V, Michaille JJ, Nuovo GJ, Croce CM. MiR-155-targeted IcosL controls tumor rejection. Proc Natl Acad Sci U S A. 2024;121(29):e2408649121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4994_CR42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1074-7613(00)00011-X","volume":"13","author":"AJ Coyle","year":"2000","unstructured":"Coyle AJ, Lehar S, Lloyd C, Tian J, Delaney T, Manning S, Nguyen T, Burwell T, Schneider H, Gonzalo JA, et al. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity. 2000;13(1):95\u2013105.","journal-title":"Immunity"},{"issue":"9","key":"4994_CR43","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/s41417-024-00790-8","volume":"31","author":"A Finizio","year":"2024","unstructured":"Finizio A, Pagano P, Napolano A, Froechlich G, Infante L, De Chiara A, Amiranda S, Vitiello E, Totaro S, Capasso C, et al. Integrating system biology and intratumor gene therapy by trans-complementing the appropriate co-stimulatory molecule as payload in oncolytic herpes virus. Cancer Gene Ther. 2024;31(9):1335\u201343.","journal-title":"Cancer Gene Ther"},{"key":"4994_CR44","doi-asserted-by":"publisher","first-page":"14340","DOI":"10.1038\/ncomms14340","volume":"8","author":"D Zamarin","year":"2017","unstructured":"Zamarin D, Holmgaard RB, Ricca J, Plitt T, Palese P, Sharma P, Merghoub T, Wolchok JD, Allison JP. Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity. Nat Commun. 2017;8:14340.","journal-title":"Nat Commun"},{"issue":"6","key":"4994_CR45","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.immuni.2019.10.009","volume":"51","author":"R Zander","year":"2019","unstructured":"Zander R, Schauder D, Xin G, Nguyen C, Wu X, Zajac A, Cui W. CD4(+) T Cell Help Is Required for the Formation of a Cytolytic CD8(+) T Cell Subset that Protects against Chronic Infection and Cancer. Immunity. 2019;51(6):1028\u2013e10421024.","journal-title":"Immunity"},{"key":"4994_CR46","doi-asserted-by":"publisher","first-page":"114300","DOI":"10.1016\/j.ejpb.2024.114300","volume":"199","author":"L Kuryk","year":"2024","unstructured":"Kuryk L, Mathlouthi S, Wieczorek M, Gad B, Rinner B, Malfanti A, Mastrotto F, Salmaso S, Caliceti P, Garofalo M. Priming with oncolytic adenovirus followed by anti-PD-1 and paclitaxel treatment leads to improved anti-cancer efficacy in the 3D TNBC model. Eur J Pharm Biopharm. 2024;199:114300.","journal-title":"Eur J Pharm Biopharm"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04994-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04994-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04994-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:08:02Z","timestamp":1789520882000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04994-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4994"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04994-7","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the Ethics Committee of The Affiliated Drum Tower Hospital, Medical School of Nanjing University (IACUC-D2402006). This study using peripheral blood lymphocytes from healthy donors was approved by the ethics committee of Nanjing Drum Tower Hospital (approval number: 2016-05-17).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"490"}}